跳至主要内容
临床试验/EUCTR2012-003217-33-DE
EUCTR2012-003217-33-DE进行中(未招募)1 期

Immunological response of a single dose of 100,000 I.U. of cholecalciferol (vitamin D3)

Charité - Universitätsmedizin Berlin0 个研究点目标入组 40 人开始时间: 2012年8月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - written informed consent
  • - men and women aged between 18 - 60 years
  • - 25-hydroxyvitamin D3 serum concentration
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Main exclusion criteria
  • - 25-hydroxyvitamin D3 serum concentration >50 nmol/l
  • - BMI <18.5 or >30 kg/m²
  • - regular or planned UV exposure
  • - hypersensitivity against ingredients of the study drug
  • - anamnesis: any disease which is a contraindication for the IMP
  • - use of vitamin A or other vitamin D derivates
  • - treatment with any medication which might interfere with the study drug or is an contra indication
  • - pregnancy and lactation

研究者

相似试验

Unknown
3 期
Immunogenicity of a single standard dose versus a double standard dose of inactivated trivalent influenza vaccine in patients on peritoneal dialysis: Open labelled Randomized control trialSafety-End stage kidney disease patients on peritoneal dialysis treatment -Healthy volunteerHigh dose influenza vaccinePeritoneal dialysisHemagglutininCellular immunityVaccinationChronic kidney disease
TCTR20220526003Health Systems Research Institute(HSRI)125
已完成
不适用
Immune response of fractional doses of Inactivated Poliovirus Vaccine (IPV) administered intradermally in the Sultanate of OmaPoliomyelitis vaccinationInfections and InfestationsPoliomyelitis
ISRCTN17418767World Health Organization (WHO) (Switzerland)400
进行中(未招募)
1 期
Evaluation of immunological response following a revaccination with a non-conjugated pneumococcal vaccine boosted or not by a conjugated pneumococcal vaccine in splenectomised patients (SPLENEVAC-2)Asplenic patients at risk for invasive pneumococcal diseasesMedDRA version: 20.0Level: PTClassification code 10041642Term: SplenectomySystem Organ Class: 10042613 - Surgical and medical procedures
EUCTR2018-003068-29-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)56
已完成
3 期
Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India
CTRI/2015/05/005770Sanofi Pasteur SA400
招募中
不适用
CIMAvax-EGF in different maintenance schemeson small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesNSCLC
RPCEC00000368Center of Molecular Immunology (CIM)42